Original language | English (US) |
---|---|
Article number | 104153 |
Journal | Cellular Immunology |
Volume | 354 |
DOIs | |
State | Published - Aug 2020 |
ASJC Scopus subject areas
- Immunology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Cellular Immunology, Vol. 354, 104153, 08.2020.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Surviving the storm
T2 - Dealing with COVID-19
AU - Vandenbark, Arthur A.
AU - Meza-Romero, Roberto
AU - Offner, Halina
N1 - Funding Information: This work was funded by the Department of Veterans Affairs , Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Merit Review Awards 2I01 BX000226 and IMMA-010-19F (AAV), Senior Research Career Scientist Award 1IK6BX004209 (AAV) and the National Institute of Allergy and Infectious Diseases award R44AI122574 (AAV). The contents do not represent the views of the Department of Veterans Affairs or the US Government. Funding Information: The authors wish to thank Ashley Headrick for help in preparing and submitting the commentary article. This work was funded by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Merit Review Awards 2I01 BX000226 and IMMA-010-19F (AAV), Senior Research Career Scientist Award 1IK6BX004209 (AAV) and the National Institute of Allergy and Infectious Diseases award R44AI122574 (AAV). The contents do not represent the views of the Department of Veterans Affairs or the US Government. The datasets used and/or analyzed during previous studies are available from the corresponding author on reasonable request. The commentary article was written, edited and reviewed by AAV, HO and RMR. All authors read and approved the final article. Drs. Vandenbark, Offner, Meza-Romero, and OHSU have a significant financial interest in Artielle ImmunoTherapeutics, Inc. a company that may have a commercial interest in the results of this research and technology. This potential conflict of interest has been reviewed and managed by the OHSU and VA Portland Health Care System Conflict of Interest in Research Committees.
PY - 2020/8
Y1 - 2020/8
UR - http://www.scopus.com/inward/record.url?scp=85086515190&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086515190&partnerID=8YFLogxK
U2 - 10.1016/j.cellimm.2020.104153
DO - 10.1016/j.cellimm.2020.104153
M3 - Letter
C2 - 32563849
AN - SCOPUS:85086515190
SN - 0008-8749
VL - 354
JO - Cellular Immunology
JF - Cellular Immunology
M1 - 104153
ER -